Content Matter Experts
Jessica Auten, PharmD, BCOP
Clinical Pharmacy Specialist, Malignant Hematology
University of North Carolina Medical Center
Assistant Professor of Clinical Education
UNC Eshelman School of Pharmacy
Chapel Hill, NC
Dr. Auten is a clinical oncology pharmacist at the University of North Carolina (UNC) Medical Center in Chapel Hill, NC. Dr. Auten received her PharmD degree from the UNC Eshelman School of Pharmacy in 2012. Since then, she has completed a PGY1 pharmacy practice residency and a PGY2 oncology pharmacy residency at the Virginia Commonwealth University Health System in Richmond, VA. Presently, Dr. Auten works as an inpatient oncology pharmacy specialist in malignant hematology. Dr. Auten’s practice and research interests focus on acute leukemia, supportive care, and patient education. She also serves as the Residency Program Director for the PGY2 oncology pharmacy residency program at UNC Medical Center.
John Bossaer, PharmD, BCOP
ETSU Bill Gatton College of Pharmacy
Johnson City, TN
John B. Bossaer, PharmD, BCOP is a Professor of Pharmacy Practice at East Tennessee State University's Bill Gatton College of Pharmacy. He provides hematology/oncology clinical pharmacy services in both the outpatient and inpatient environments at the Johnson City Medical Center and its affiliated Regional Cancer Center. A native of the one-stoplight town of Reynolds, IN, Dr. Bossaer earned his PharmD from Purdue University in 2007. The diehard Boilermaker then completed his PGY1 Pharmacy and PGY2 oncology pharmacy residencies at the Medical University of South Carolina (MUSC). Following completion of residency training, he started his career at ETSU's College of Pharmacy in 2009. His research and scholarly pursuits involve optimizing supportive care of patients receiving chemotherapy, oral chemotherapy patient education & monitoring, and drug-drug interactions with oral oncolytics. He is an active member of the Hematology Oncology Pharmacy Association (HOPA). He also hosts and produces OncoPharm, an oncology pharmacy podcast available wherever you get podcasts.
Ryan Bycroft, PharmD, BCOP
Clinical Oncology Pharmacist
University of Louisville Hospital, Brown Cancer Center
Ryan Bycroft is the clinical pharmacy supervisor for oncology at University of Louisville Health, Brown Cancer Center. He originally graduated from Duquesne University in Pittsburgh, Pa. Ryan is the primary clinical pharmacist for melanoma multidisciplinary clinic and covers other various oncology areas included the inpatient oncology unit. Ryan has been working at the Brown Cancer Center for 15 years.
Courtney C. Cavalieri, PharmD, BCOP
Clinical Oncology Pharmacist
Huntsman Cancer Institute at the University of Utah
Salt Lake City, UT
Dr. Courtney C. Cavalieri is a clinical oncology pharmacist at the Huntsman Cancer Institute at the University of Utah. She completed her Doctor of Pharmacy at Philadelphia College of Pharmacy, her PGY1 Pharmacy Practice residency at the University of Colorado Hospital, and her PGY2 Oncology Pharmacy residency at Memorial Sloan-Kettering Cancer Center. Since completing her PGY2 in 2013, she has worked at Huntsman in Salt Lake City and is a Board Certified Oncology Pharmacist. She currently rotates between two ambulatory clinics that care for patients with gastrointestinal, thoracic, and head and neck malignancies, as well as those on investigational therapeutics. Her role also includes precepting PGY2 oncology pharmacy residents, PGY1 pharmacy practice residents, and pharmacy students. At Huntsman, she is one of the Oncology Residency Program Coordinators in addition to serving on the Patient Education Committee and the Protocol Review and Monitoring Committee as a pharmacy services representative. She also participates on the Chemotherapy Order Template committee for NCCN, the Annual Conference Abstract Review Subcommittee for HOPA, and is a past-president of the Utah Society of Health-System Pharmacists.
Brette Conliffe, PharmD, BCOP
Clinical Oncology Pharmacy Supervisor
University of Louisville Health/Brown Cancer Center
Brette Conliffe, PharmD, BCOP is a clinical oncology pharmacy supervisor in Louisville, Kentucky at the Brown Cancer Center/University of Louisville Hospital. She received her undergraduate degree in chemistry at Centre College and her PharmD from the University of Kentucky. She completed two years of residency at the University of Louisville Hospital/Brown Cancer Center, specializing in oncology. Her current area of clinical practice is in the outpatient solid tumor clinics (primarily focusing on genitourinary and gastrointestinal cancers). She precepts a variety of PGY1, PGY2, and student rotations. Recent research projects include implementation of a pharmacy student-run oral antineoplastic follow up program, impact of antibiotics on gemcitabine efficacy and safety, and effect of CYP interactions on doxorubicin efficacy and safety. She serves as a guest lecturer for oncology topics at Sullivan College of Pharmacy and is the Oncology P&T Subcommittee secretary. She was named "40 Under 40 in Cancer" by the Lynx Group in 2021 and will graduate from ASHP's Pharmacy Leadership Academy (PLA) in 2023.
Karen M. Fancher, PharmD, BCOP
Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Clinical Pharmacy Specialist, Oncology
University of Pittsburgh Medical Center Passavant
Karen M. Fancher, PharmD, BCOP, is an Associate Professor of Pharmacy Practice at Duquesne University School of Pharmacy in Pittsburgh, Pennsylvania. She is a graduate of Duquesne University School of Pharmacy and completed a Pharmacy Practice Residency at Thomas Jefferson University Hospital in Philadelphia, followed by a Specialty Residency in Oncology Pharmacy Practice at the H. Lee Moffitt Cancer Center and Research Institute in Tampa. She then spent almost 10 years as a Clinical Pharmacist in the Blood and Marrow Transplant Division at the H. Lee Moffitt Cancer Center before returning to Pittsburgh to work with the West Penn Allegheny Oncology Network. Dr. Fancher's current practice site is the University of Pittsburgh Medical Center at Passavant Hospital. She presently serves on the faculty for the Board Certification in Oncology Pharmacy (BCOP) Review & Recertification course, as well as on various committees of the Hematology Oncology Pharmacy Association (HOPA). She has repeatedly been voted as the “Teacher of the Year” by students in the School of Pharmacy and has also been nominated for ASHP's Preceptor of the Year Award. Dr. Fancher's research interests include chronic leukemias, lymphomas and ethics in oncology.
Christopher Fausel, PharmD, MHA, BCOP
Director of Pharmacy Precision Genomics
Indiana University Health
Chairman of the Board
Hoosier Cancer Research Network
Christopher Fausel, PharmD, MHA, BCOP, is the Director of Pharmacy for Precision Genomics Oncology at the Indiana University Simon Comprehensive Cancer Center (IUSCCC) in Indianapolis, Indiana where he coordinates the institutional molecular tumor board. He graduated from Albany College of Pharmacy with a BS Pharmacy in 1993 and PharmD in 1996 and completed residency training at the Stratton VA Medical Center in Albany, NY. In addition, he is the Chairman of the Board of the Hoosier Cancer Research Network, a non-profit organization that conducts clinical trials and translational research in cancer and serves as the administrative headquarters of the Big Ten Cancer Research Consortium. He is the founding Residency Program Director for the PGY2 Oncology Pharmacy Residency and has previously served as a clinical specialist in hematology/oncology/stem cell transplant and as a clinical manager for oncology pharmacy for over 20 years at Indiana University Health. He serves as Chair for the Indiana University biomedical IRB. He is a long-standing member of ASHP, ASCO and HOPA.
Lauren Ice, PharmD, BCOP, BCPS
Clinical Pharmacy Specialist
Grand Rapids, MI
Lauren Ice is a clinical pharmacy specialist for cancer health at Corewell Health in Grand Rapids, Michigan. She received her Doctor of Pharmacy degree from Ohio Northern University and completed her PGY1 and PGY2 Oncology Residency at Mayo Clinic in Rochester, MN. Dr. Ice's clinical practices areas include hematopoietic cell transplant and immune effector cell therapy, and she is actively involved in patient care, research, and education in her current role. She is board certified in pharmacotherapy and oncology.
Alexis R. Jones, PharmD, BCOP, CPP
Clinical Pharmacist, Gynecologic Oncology
University of North Carolina Medical Center
Chapel Hill, NC
Alexis Jones, PharmD, BCOP, CPP has been a clinical pharmacist at the University of North Carolina (UNC) Gynecologic Oncology Outpatient clinic since 2017 after completing a two-year residency specializing in oncology. She has a board certification in oncology as well as a clinical pharmacist practitioner license. Alexis serves as an adjunct assistant professor of clinical education at the University of North Carolina Eshelman School of Pharmacy.
Elyse A. MacDonald, PharmD, MS, BCPS
Director, Investigational Drug Service
Stanford Health Care
Palo Alto, CA
Elyse MacDonald, PharmD, MS, BCPS is a director of pharmacy services with a focus in research pharmacy at Stanford Health Care. Previously, she was the pharmacy manager for the Investigational Drug Service at the University of Utah Health. Prior to this position, she was a drug information specialist with the University of Utah Drug Information Service.
She has presented the research design and statistics module for the ASHP/ACCP Oncology Pharmacy Review and Recertification Course since 2014. She also presents on various topics related to research pharmacy practices. She is a member of the Editorial Advisory Board for AJHP. Dr. MacDonald was appointed as a member of the ASHP Commission on Affiliate Relations from 2017-2020. She has been a member of ASHP SCSS Section Advisory Group (SAG) on Emerging Sciences and the Clinical Leadership SAG. She also served as a network facilitator for Pharmacoeconomics and Drug Policy Development. Elyse is also a past-president for the Utah Society of Health-System Pharmacists. She served as a Utah delegate in 2016, 2017, 2018, 2019, and 2023 for the ASHP House of Delegates.
Janelle Mann, PharmD, BCOP
Manager of Clinical Pharmacy Services/Clinical Oncology Pharmacist
Washington University School of Medicine/Siteman Cancer Center
St. Louis, MO
Janelle Mann is a clinical oncology pharmacist at Siteman Cancer Center / Washington University School of Medicine in St. Louis, MO. She completed her Doctor of Pharmacy at St. Louis College of Pharmacy in 2009. She went on to complete both PGY1 Pharmacy Practice and PGY2 Oncology Pharmacy residencies at Froedtert Hospital in Milwaukee, WI. She currently practices in an ambulatory clinic focusing on thoracic malignancies as well as other medical oncology areas. She serves as the manager of clinical pharmacy services at Siteman Cancer Center and precepts residents from the PGY2 Oncology program at Barnes-Jewish Hospital. She also serves as adjunct faculty at St. Louis College of Pharmacy teaching in the area of oncology. She is a board certified oncology pharmacist.
Colleen McCabe, PharmD, BCOP
Clinical Oncology Pharmacy Specialist, Sarcoma and Melanoma
Vanderbilt University Medical Center
Dr. McCabe is a Board-Certified Oncology Pharmacist practicing as the Clinical Pharmacist Specialist in Adult Sarcoma and Melanoma at Vanderbilt University Medical Center. She received her Doctorate of Pharmacy from the University of North Carolina at Chapel Hill. Upon graduation, she completed her Pharmacy Practice and Oncology Pharmacy Residencies at Emory University Hospital Midtown in Atlanta, GA.
Outside of her clinical responsibilities, she serves as a content contributor for the sarcoma chemotherapy regimens for ChemoExperts.com and is the Oncology Chair for the Pharmacy Research Forum at Vanderbilt. She has published on topics such as the pharmacist role in management of oral oncolytics, assessment of infusion related research surrounding pharmacist-based interventions in oncology and mentoring pharmacy residents and students.
Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP
Clinical Oncology Pharmacy Manager
Levine Cancer Institute
Donald C. Moore, PharmD, BPCS, BCOP, DPLA, FCCP graduated from Massachusetts College of Pharmacy and Health Sciences in Boston, MA. He completed a Pharmacy Practice Residency at Steward St. Elizabeth’s Medical Center in Boston, MA. Dr. Moore is the Clinical Oncology Pharmacy Manager at Levine Cancer Institute, Atrium Health in Charlotte, NC. He currently practices in the area of hematologic malignancies. Dr. Moore is a graduate of ASHP Foundation Pharmacy Leadership Academy and a fellow of ACCP.
Anthony J. Perissinotti, PharmD, BCOP
Hematology Clinical Pharmacist Specialist
University of Michigan
Ann Arbor, MI
Anthony J. Perissinotti, PharmD, BCOP, is a hematology clinical pharmacist specialist at the University of Michigan – Michigan Medicine, clinical team leader of hematology/oncology, and adjunct clinical assistant professor at the University of Michigan College of Pharmacy in Ann Arbor, Michigan. Dr Perissinotti obtained his Doctor of Pharmacy degree from Wayne State University in Detroit, Michigan. He completed his first year of postgraduate residency at the Detroit Medical Center and he completed his second year of postgraduate residency training at The University of Texas MD Anderson Cancer Center in Houston. Dr Perissinotti is a board-certified hematology/oncology pharmacist..
Danielle Roman, PharmD, BCOP
Manager, Oncology Clinical Pharmacy Services
Allegheny Health Network
Danielle Roman, PharmD, BCOP is the manager for oncology clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, Pennsylvania. Her clinical practice is focused on cancer care for a large ambulatory community practice. She has served as adjunct clinical instructor for Duquesne University School of Pharmacy and lectures at the University of Pittsburgh School of Pharmacy. She serves as the residency program director for the PGY2 oncology resident program at Allegheny General Hospital. Dr. Roman received her Doctor of Pharmacy from the Duquesne University School of Pharmacy and completed her post-graduation residency training at The Johns Hopkins Hospital where she specialized in oncology pharmacy. Her research and scholarly activities focus on breast cancer, melanoma, and the management of oral anticancer agents.
Christine M. Walko, PharmD, BCOP, FCCP
Senior Member, Individualized Cancer Management, Precision Medicine Team Lead
Moffitt Cancer Center
Christine M. Walko graduated with her PharmD degree from Duquesne University in Pittsburgh, Pennsylvania, and completed a pharmacy practice residency at the Medical College of Virginia/VCU in Richmond, Virginia, and a hematology/oncology specialty residency at the University of North Carolina (UNC). She stayed at UNC to complete a 2-year academic oncology fellowship focused on drug metabolism and translational research before taking an assistant professor position at UNC in the Division of Pharmacotherapy and Experimental Therapeutics. Dr. Walko is now a Senior Member in the Department of Individualized Cancer Management, Team Lead for Precision Medicine and Attending for the Personalized Medicine Clinical Service. She also serves on the ASCO TAPUR Molecular Tumor Board. Her research focus is on optimizing drug therapy using pharmacogenomics and pharmacokinetics to personalize intravenous and oral anticancer therapy for patients with cancer.
Jennifer Young, PharmD, BCOP
Clinical Pharmacy Specialist – Pediatric Hematology/Oncology
Cincinnati Children’s Hospital Medical Center
Jennifer Young is a clinical pharmacy specialist at Cincinnati Children's Hospital Medical Center where she specializes in pediatric oncology. She is also an Adjunct Assistant Professor of Clinical Pharmacy at the University of Cincinnati College of Pharmacy. Jennifer graduated with her PharmD from Duquesne University in 2011 and subsequently completed her PGY1 at the University of Chicago Medical Center and PGY2 in pediatric oncology at Memorial Sloan-Kettering Cancer Center. Jennifer is a Board Certified Oncology Pharmacist and an active member of ASHP, HOPA and the Children's Oncology Group.